By Dr Joanna Elizabeth Fardell

Journal articles

Noll KR; Fardell J, 2015, 'Comment on “Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment”', Frontiers in Oncology, 5, pp. 137, http://dx.doi.org/10.3389/fonc.2015.00137

Noll KR; Fardell JE, 2015, 'Commentary: "Neuropsychological assessment of individuals with brain tumor: Comparison of approaches used in the classification of impairment"', Frontiers in Oncology, 5, http://dx.doi.org/10.3389/fonc.2015.00188

Fardell JE; Zhang J; De Souza R; Vardy J; Johnston I; Allen C; Henderson J; Piquette-Miller M, 2014, 'The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice', Psychopharmacology, 231, pp. 841 - 852, http://dx.doi.org/10.1007/s00213-013-3301-8

Price MA; Butow PN; Bell ML; Webb PM; deFazio A; Friedlander M; Fardell JE, 2013, 'PSYCHOSOCIAL PREDICTORS OF SURVIVAL IN WOMEN WITH INVASIVE OVARIAN CANCER: A POPULATION-BASED PROSPECTIVE STUDY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 9, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fardell JE; Vardy J; Johnston IN, 2013, 'The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory', Life Sciences, 93, pp. 596 - 604, http://dx.doi.org/10.1016/j.lfs.2013.05.006

Butow PN; Bell M; Smith A; Fardell JE; Thewes B; Turner J; Gilchrist JA; Beith J; Girgis A; Sharpe L; Shih S; Mihalopoulos C, 2013, 'Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence', BMC Cancer, 13, http://dx.doi.org/10.1186/1471-2407-13-201

Hicks C; Jorgensen W; Brown C; Fardell J; Koehbach J; Gruber CW; Kassiou M; Hunt GE; Mcgregor IS, 2012, 'The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor-Binding Profile, Prosocial Effects and Distribution of c-Fos Expression in Adolescent Rats', Journal of Neuroendocrinology, 24, pp. 1012 - 1029, http://dx.doi.org/10.1111/j.1365-2826.2012.02311.x

Fardell JE; Vardy J; Shah JD; Johnston IN, 2012, 'Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity', Psychopharmacology, 220, pp. 183 - 193, http://dx.doi.org/10.1007/s00213-011-2466-2

Sharpe MJ; Fardell JE; Vardy JL; Johnston IN, 2012, 'The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats', Behavioural Brain Research, 227, pp. 295 - 299, http://dx.doi.org/10.1016/j.bbr.2011.11.0

Fardell JE; Vardy J; Johnston IN; Winocur G, 2011, 'Chemotherapy and cognitive impairment: Treatment options', Clinical Pharmacology and Therapeutics, 90, pp. 366 - 376, http://dx.doi.org/10.1038/clpt.2011.112

Seigers R; Fardell JE, 2011, 'Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research', Neuroscience and Biobehavioral Reviews, 35, pp. 729 - 741, http://dx.doi.org/10.1016/j.neubiorev.2010.09.006

Price MA; Butow PN; Costa DSJ; King MT; Aldridge LJ; Fardell JE; DeFazio A; Webb PM, 2011, 'MJA: Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carergivers', Medical Journal of Australia, 195, pp. 232 - 232, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03294.x

Fardell JE; Vardy J; Logge W; Johnston I, 2010, 'Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents', Pharmacology Biochemistry and Behavior, 97, pp. 333 - 339, http://dx.doi.org/10.1016/j.pbb.2010.08.019

Price MA; Butow PN; Costa DSJ; King MT; Aldridge LJ; Fardell JE; deFazio A; Webb PM, 2010, 'Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers', Medical Journal of Australia, 193, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03929.x

Back to profile page